{"prompt": "['GALDERMA R&D', 'RD.06.SPR.118295 Protocol V02 04Jun2019', 'Page 49 of 88', 'CC', 'Table 5', 'Suspected sensitization - reaction grading', 'Score', 'Morphology', 'Interpretation', '-', 'No skin changes in the tested area', 'Negative', '?', 'Faint, non-palpable erythema', 'Doubtful reaction', '+', 'Palpable erythema (moderate edema or infiltrate), papules not', 'Weak positive reaction', 'present or scarce, vesicles not present', '++', 'Strong infiltrate, numerous papules, vesicles present', 'Strong positive reaction', '+++', 'Erythema, infiltration, confluent vesicles, bullae or ulceration', 'Extreme positive reaction', 'ir', 'Inflammation sharply limited to the exposed area, lack of infiltrate,', 'Irritant reaction', 'small petechiae, pustules, and efflorescences other than papules', 'and vesicles', 'Nt', 'Not tested', '8.', 'At the last reading, the investigator will provide an interpretation regarding a possible', 'sensitization reaction using the following scale:', 'Table 6', 'Suspected sensitization - conclusion']['GALDERMA R&D', 'RD.06.SPR.118295 Protocol V02 04Jun2019', 'Page 50 of 88', 'Sensitization Reaction', '0', 'Negative (absence of reaction or might be irritant reaction)', '1', 'Equivocal', '2', 'Positive', 'CCI', 'b) In case of suspicion of immediate contact skin reaction (such as urticaria)', 'A case-by-case approach will be applied and the procedure to follow will be discussed with the', 'Sponsor.', '7.2.2.2.5', 'Procedures for reporting pregnancies', 'Any pregnancy occurring during clinical trials, where the fetus could have been exposed to the', 'study drug, must be monitored until its outcome in order to ensure the complete collection of safety', 'data on GALDERMA R&D products.', 'If a subject becomes pregnant, the Investigator is to do the following:', '1.', 'Withdraw the subject from the clinical trial.', 'CCI']['GALDERMA R&D', 'RD.06.SPR.118291 Protocol V02 04Jun2019', 'Page 51 of 88', '5.', 'At the outcome of the pregnancy, complete the Pregnancy Surveillance Form - Part II:', 'Course and Outcome of Pregnancy, as fully as possible. Inform the CSO by telephone, then', 'fax or scan and send by e-mail this pregnancy form to the CSO within 24 hours.', '6.', 'If the pregnancy leads to an abortion (voluntary, spontaneous or therapeutic), in-utero', 'death, or congenital anomaly, follow the procedure for declaration of an SAE', '(see Section 7.2.2.2.2).', '7.3', 'Other assessments', '7.3.1', 'Photographs', 'CCI']\n\n###\n\n", "completion": "END"}